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Abstract
Persistent alterations of proopiomelanocortin (Pomc) and mu-opioid receptor
(Oprm1) activity and stress responses after alcohol are critically involved in vulnera-
bility to alcohol dependency. Gene transcriptional regulation altered by alcohol may
play important roles. Mice with genome-wide deletion of neuronal Pomc enhancer1
(nPE1−/−), had hypothalamic-specific partial reductions of beta-endorphin and dis-
played lower alcohol consumption, compared to wildtype littermates (nPE1+/+). We
used RNA-Seq to measure steady-state nuclear mRNA transcripts of opioid and
stress genes in hypothalamus of nPE1+/+ and nPE1−/− mice after 1-day acute with-
drawal from chronic excessive alcohol drinking or after water. nPE1−/− had lower
basal Pomc and Pdyn (prodynorphin) levels compared to nPE1+/+, coupled with
increased basal Oprm1 and Oprk1 (kappa-opioid receptor) levels, and low alcohol
drinking increased Pomc and Pdyn to the basal levels of nPE1+/+ in the water group,
without significant effects on Oprm1 and Oprk1. In nPE1+/+, excessive alcohol
intake increased Pomc and Oprm1, with no effect on Pdyn or Oprk1. For stress
genes, nPE1−/− had lowered basal Oxt (oxytocin) and Avp (arginine vasopressin) that
were restored by low alcohol intake to basal levels of nPE1+/+. In nPE1+/+, exces-
sive alcohol intake decreased Oxt and Avpi1 (AVP-induced protein1). Functionally
examining the effect of pharmacological blockade of mu-opioid receptor, we found
that naltrexone reduced excessive alcohol intake in nPE1+/+, but not nPE1−/−. Our
results provide evidence relevant to the transcriptional profiling of the critical
genes in mouse hypothalamus: enhanced opioid and reduced stress gene tran-
scripts after acute withdrawal from excessive alcohol may contribute to altered
reward and stress responses.
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1 | INTRODUCTION
The endogenous opioid systems are profoundly changed by alcohol.
Specifically, for the proopiomelanocortin (POMC) in the hypothala-
mus, alcohol alters the Pomc gene expression levels after chronic
alcohol consumption1-3 or after prolonged withdrawal.4 Because acti-
vation of mu-opioid receptor (MOP-r) by beta-endorphin (encoded by
Pomc) is rewarding5,6 and modulates dopamine release,7 alcohol-
induced beta-endorphin release8-10 could play a role in the reinforcing
effects of alcohol, its motivational behaviors and consumption.
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Indeed, numerous pharmacological studies provide consistent evi-
dence that the MOP-r blockade with antagonist naltrexone or nalox-
one decreases alcohol reward, consumption, reinstatement of alcohol
seeking and relapse-like drinking in rodents, as well as alcohol drink-
ing, craving and relapse episodes in human alcoholics, further indicat-
ing that the beta-endorphin/MOP-r is critically involved in the
regulation of alcohol consumption.11 Determining the specific role of
hypothalamic POMC neurons in alcohol drinking behaviors, we
recently used transgenic mice with hypothalamic-specific POMC dele-
tion resulting in brain-specific beta-endorphin deficiency12 and
showed that the hypothalamic-POMC deficient mice drink less alco-
hol.13 Further, pharmacological blockade of MOP-r with naltrexone
dose-dependently decreased intake in the wildtype mice but showed
a blunted effect in the hypothalamic-POMC deficient mice.13
Together, the above results suggest that beta-endorphin and MOP-r
play a critical role in modulation of alcohol consumption, probably via
a hypothalamic POMC neuron-mediated mechanism.
Results from both clinic and preclinical studies have showed pro-
found alterations of stress responsive systems after chronic alcohol
abuse. Specifically, alcohol has direct or downstream effects on several
hypothalamic stress-responsive systems, including arginine vasopressin
(AVP),11,14,15 oxytocin,16 corticotrophin releasing hormone (CRH) and
their receptors,17 dynorphin and the kappa opioid receptors (KOP-r).18,19
The studies in both humans and rodents also provide clear support for
the importance of these stress responsive systems in the process of alco-
hol consumption with strong interactions with hypothalamic-pituitary-
adrenal (HPA) hormones and their receptors (eg, glucocorticoid recep-
tors), especially after stress.20,21 Although acute exposure to alcohol pro-
foundly activates the HPA axis, many alcoholics or rats develop HPA
tolerance after chronic alcohol exposure.22,23
Based on the above background, we propose a hypothesis that
gene transcriptional regulation in the hypothalamus at basal levels or
altered by alcohol plays important roles in individual vulnerability to
excessive alcohol drinking. RNA sequencing (RNA-Seq) provides rela-
tively accurate, highly sensitive and reliable gene expression data,
although this technology for quantification analysis is still in a devel-
opmental stage.24 Therefore, high-throughput RNA-Seq of total RNAs
was performed for comprehensive molecular profiling of the mouse
hypothalamus to identify changes in genes expression after chronic
excessive alcohol drinking. For this purpose, mice, subjected to 4-day
drinking-in-the-dark (DID) paradigm followed by a 3-week chronic
intermittent access (IA) drinking paradigm (two-bottle choice, 24-hour
access every other day), developed high alcohol consumption
(15-25 g/kg/day).13,25 As altered mRNA changes in the nuclear com-
partment are more direct and sensitive to the gene transcriptional
activation than those in the cytoplasmic compartment,26-29 we ana-
lyzed hypothalamic gene transcripts using nuclear RNAs, to determine
transcriptional alterations after 1-day withdrawal from chronic IA
drinking. Firstly, neuronal Pomc enhancer1 knockout (nPE1−/−) mice
with hypothalamic-specific partial loss of Pomc transcriptional activ-
ity12 was used to confirm that nPE1−/− mice, in comparison with
nPE1+/+ mice, had lowered nuclear Pomc transcript levels in the hypo-
thalamus. Then using the nPE1 knockout, we purposely mimic possible
genetic variations in humans with less Pomc expression and/or function,
and tested how the Pomc partial deficiency is involved in excessive alco-
hol drinking, the question that cannot be answered using the mice with
complete POMC deletion.12,13 As naltrexone blocks MOP-r, we further
examined whether naltrexone could reduce alcohol drinking in nPE1−/−
mice as a genetic control for the effects of the MOP-r antagonist. As
individual vulnerability to excessive alcohol drinking is a key feature of
alcohol addiction, we tested whether the genetically determined vulner-
ability to excessive alcohol drinking between nPE1+/+ (high intake) and
nPE1−/− (low intake) mice were associated with alterations of related
transcriptome profile in the hypothalamus, specifically the opioid and
stress genes. Finally, stress hormone corticosterone levels were deter-
mined to provide functional validation about the stress gene trans-
criptome profiling in the hypothalamus of both nPE1+/+ and nPE1−/−
mice after acute alcohol withdrawal.
2 | METHODS AND MATERIALS
2.1 | ANIMALS
Male littermates with neuronal Pomc enhancer1 knockout (nPE1−/−)
and wildtype (nPE1+/+) were screened by polymerase chain reaction
(PCR) analysis of genomic DNA extracted from mouse tail biopsies, as
described previously.12 The gene mutation was generated by homolo-
gous recombination in 129S6/SvEvTac Taffy embryonic stem cells to
produce the chimeric founder mice, followed by approximately 16 gen-
erations of backcrossing onto the C57BL/6J strain. Specifically, in
these transgenic mice, deletion of nPE1 in the context of intact nPE2
and Pomc pituitary enhancer regions and the proximal promoter
reduces Pomc expression by 50%-70% in the hypothalamic arcuate
nucleus, without altering Pomc expression in pituitary cells. Hypotha-
lamic content of beta-endorphin and melanocortin are reduced by
approximately 70% in the mutant mice compared to wildtype
controls.12
Male nPE1−/− and nPE1+/+ littermates (9-10-week-old) derived
from heterozygous nPE1+/− parents were used for all the present
experiments. All mice were given ad libitum access to food and water
in a stress-minimized facility and housed in individual and ventilated
cages fitted with steel lids and filter tops. Mice were placed on a
12-hour reverse light-dark cycle (lights off at 7:00 AM). Animal care
and experimental procedures were conducted according to the Guide
for the Care and Use of Laboratory Animals (Institute of Laboratory Ani-
mal Resources Commission on Life Sciences 1996). The experimental
protocols were approved by the Institutional Animal Care and Use
Committee of the Rockefeller University.
2.2 | PROCEDURES
2.2.1 | The DID procedure followed by chronic
(3 weeks) IA drinking procedure (Table S1)
In the DID model, after the beginning of the dark period, mice had
access to alcohol drinking with limited time (4 hours/day) in their
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home cages, and with food available in a one-bottle paradigm with
alcohol exposure every day for 4 days.30 The basic paradigm with our
modifications was as follows13: At the time when the mice started
individual housing (1 week before the experiments), the water bottle
was replaced with that with sipper tubes to acclimate the mice to the
sipper tube. Beginning at 10:00 AM (3 hours after lights off) the water
bottle was replaced with an alcohol pipette that was fitted with a
stainless-steel straight sipper tube (containing a ball bearing at the
end to prevent alcohol leakage) and sealed with a rubber stopper. The
alcohol tube was refilled with fresh alcohol solution, kept for 4 hours
and then replaced with a water bottle. In all the experiments, 15%
(v/v) alcohol solution was prepared by mixing alcohol with tap water
to reach 15% alcohol concentration in tap water. Body weight was
recorded every day, and alcohol intake value (ie, g/kg) was recorded
after 4 hours of alcohol access every day.
After the 4-day DID in the first week, the mice always had access
to alcohol in the home cage for 3 weeks with food and water available
in a two-bottle free choice paradigm, with alcohol drinking every
other day. This IA model was like an earlier protocol,25 with some
modifications.13 The procedures were identical to the DID described
above with the following exceptions: Beginning at 3 hours after lights
off, both the 15% alcohol solution and water tubes were provided on
home cages. The left /right position of the tubes was randomly chan-
ged every other day to avoid the possible side preference. After 4, 8
and 24 hours of alcohol access, both alcohol and water intake values
were recorded, and these data were used to calculate alcohol intake
(ie, g/kg) and relative preference for alcohol (ie, alcohol intake/total
fluid intake). Access to alcohol following the 3-week procedure led to
high alcohol intake in the mice.13 As with the above DID model, we
purposely monitored alcohol drinking at the beginning of the dark
period, the 4-hour time point. To evaluate alcohol drinking in the cir-
cadian active dark cycle, alcohol and water intake values were also
recorded at 8- and 24-hour recording times.
In the experiment of transcriptome profiling and stress hormone
(Table S1A), the water control groups for each genotype were run in
parallel under identical procedures (eg, two water bottles every other
day during 3-week IA), but without alcohol available. As shown in
Table S2, body weight data were recorded at several key time points
for both genotypes.
2.2.2 | RNA extraction
Mice in both alcohol and water groups were sacrificed 24 hours after
the last IA session by decapitation with brief (10 seconds) CO2 expo-
sure; the hypothalamus was dissected from the brain and frozen on
dry ice immediately (Table S1A). The snap-frozen hypothalamus was
fractionated into nuclear and cytoplasmic phases using the double-
detergent lysis buffer and disposable tuberculin syringes with
22-gauge (0.40 mm id) needles as homogenizers.28 Briefly, the hypo-
thalamus was lysed by the addition of 0.5 mL/sample 0.3 M sucrose
lysis buffer and layered over a 0.80-mL cushion of 0.4 M sucrose lysis
buffer. Samples were centrifuged at 300 × g for 15 minutes at 4C.
The supernatant (cytoplasmic fraction) was transferred to a fresh tube,
treated with proteinase K (Boehringer Mannheim, Indianapolis,
Indiana) for 1 hour at 45C. The remaining 0.4-M sucrose cushion was
removed, and the nuclear pellet was washed with 0.5 mL 0.4 M
sucrose and centrifuged again. The supernatant was removed, and the
nuclear pellet was treated with RNase-free DNase-1 (Worthington,
Biochemicals, Freehold, New Jersey) for 5 minutes at 37C, followed
by a 30 minutes proteinase K treatment at 45C. Finally, the nuclear
RNA was added with Qiazol (Qiagen, Valencia, California), and the
total nuclear RNA was isolated using the miRNeasy kit (Qiagen), and
the quality and quantity of nuclear RNA from each sample was deter-
mined using an Agilent 2100 Bioanalyzer. This method permits effi-
cient lysis of the tissue as evidenced by absence of the cytoplasmic
tRNA in the nuclear fraction, with minimal rupture of nuclei as indi-
cated by the absence of DNA in the cytoplasmic fraction, even with
very vigorous homogenization.31
2.2.3 | RNA-seq library preparation and sequencing
RNA-seq library preparation and sequencing of samples isolated from
mouse hypothalamus was performed by the Genomic Resource Cen-
ter at the Rockefeller University. Hypothalamic RNA-seq libraries
were prepared using Illumina's TruSeq Stranded Total RNA Library
Prep Kit with Ribo-Zero following manufacturer protocol. Libraries
were prepared with unique barcodes and pooled at equal molar ratios.
Briefly, starting with 100 ng total nuclear RNA, the RNA was fragmen-
ted by incubating at 94C for 8 minutes with divalent cations. The
cleaved RNA fragments were copied into first strand cDNA using
reverse transcriptase and random primers. This was followed by sec-
ond strand cDNA synthesis using DNA polymerase I and RNaseH.
The double stranded cDNA fragments then had the addition of a sin-
gle “A” nucleotide to prevent self-ligation during the subsequent addi-
tion of the indexing adapters. PCR was then used to enrich only those
DNA fragments that had adapter molecules on both ends to amplify
the amount of DNA in the library. Libraries were validated using
Agilent Tape Station High Sensitivity DNA kits and normalized. Librar-
ies were multiplexed, 12 samples per lane and sequenced. Illumina
NextSeq 500 sequencer using high output V2 reagents and NextSeq
Control Software v1.4 to generate 75 bp paired end reads, following
manufacture protocol.
2.2.4 | RNA-seq data quality assessment and
differential transcript analysis
The fastq files were generated by configuring BclToFastq.pl from
CASAVA v1.8.2 with the following parameters: –ignore-missing-stats,
−-ignore-missing-bcl, −-ignore-missing-control, −-positions-format,
clocs, −-fastq-cluster-count 350 000 000. They were then examined
using FASTQC.32 The reads were aligned to the mouse reference
genome (version mm10) using STAR v2.333 aligner with default
parameters. The alignment results were then evaluated through
qualimap v2.2 (https://academic.oup.com/bioinformatics/article/32/
2/292/ 1 744 356) to ensure that all the samples had a consistent
alignment rate, and no obvious 50 or 30 bias. Aligned reads were
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summarized through feature Counts34 with the gene model from
Ensembl (Mus_musculus.GRCm38.75.gtf) at gene level: specifically,
the uniquely mapped reads (NH “tag” in bam file) that overlapped with
an exon (feature) by at least 1 bp were counted and then the counts
of all exons annotated to an Ensembl gene (meta features) were
summed into a single number. Only protein coding genes were used
for the downstream analysis of this study. Principal Component Anal-
ysis was then applied to the normalized count of all the samples from
the hypothalamus to detect potential outliers. As shown in Figure S1,
two samples in groups A and B did not cluster with the rest of the
samples under the same conditions. After careful review of the proce-
dures (littermate, cohort, dissection, extraction, etc.), we noted that
the individual variability was not attributable to any obvious technical
issue, and could not exclude that this level of variation was not biolog-
ical. Therefore, we analyzed all the samples so that we could present
our data in an unbiased way. Different transcript Seq235 was applied
to the normalized counts to estimate the fold change between the
samples from mice that had chronic alcohol drinking and those from
water controls in each genotype, using negative binomial distribution.
The genes selected for analysis are opioid and stress genes
(Table S3). The rationale for such selections came from our following
experiments to provide pharmacological data using opioid receptor
antagonist naltrexone (Section 5) and neuroendocrine on stress hor-
mone corticosterone levels (Section 6).
2.2.5 | Genotype effect on alcohol drinking with
acute administration of naltrexone in male nPE1 mice
The objective of this experiment was to determine whether a poten-
tial genotype difference after chronic excessive drinking with MOP-r
blockade by naltrexone. For each dose of naltrexone (1 or 2 mg/kg),
separate groups of male nPE1 mice were used. On the test day after
the IA paradigm (Table S1B), alcohol was presented 10 minutes after a
single injection of naltrexone or vehicle (saline), and then alcohol and
water intake values were recorded.
2.2.6 | Genotype effect on plasma corticosterone
levels
The objective of this experiment was to determine whether a poten-
tial genotype difference after chronic excessive drinking on stress hor-
mone levels. At the time of decapitation (1 day after 3-week IA
paradigm) (Table S1A), blood from each mouse was collected in
ethylenediaminetetraacetic acid-containing tubes, placed on ice, and
spun in a centrifuge at 4C. Corticosterone levels were assayed using
a rat corticosterone 125I kit from MP Biomedicals (Costa Mesa, Cali-
fornia). All values were determined in duplicate in a single assay.
2.2.7 | Blood ethanol concentration
In a separate set of experiment (Table S1C), mice were subjected to
the 4-day DID paradigm followed by a 3-week IA drinking paradigm.
In session 11, alcohol intake values were recorded after 4-hour
alcohol drinking, and then plasma from each mouse was collected as
described above. Blood ethanol concentration (BEC) levels were
assayed with the EnzyChrom kit (BioAssay Systems, Hayward, CA). All
values were determined in duplicate in a single assay.
2.2.8 | Statistical analysis on data
For behavioral data, group differences (alcohol intake or preference
ratios were analyzed using two-way ANOVA for genotype (nPE1+/+ vs
nPE1−/−) and time (4-, 8-, 24-hour recording times, or 1, 4 days) or
three-way ANOVA for genotype (nPE1+/+ vs nPE1−/−), treatment (nal-
trexone vs saline) and time (4-, 8-, 24-hour recording times) followed by
Newman-Keuls post-hoc tests. For gene transcript or corticosterone data,
group differences were analyzed using two-way ANOVA for genotype
(nPE1+/+ vs nPE1−/−) and treatment (alcohol vs water) followed by
Newman-Keuls post-hoc tests. To explore possible relationships between
individual gene transcript level and vulnerability to alcohol drinking, the
last 24-hour alcohol intake and gene transcript were examined by linear
regression. The accepted level of significance for all tests was P < .05. All
statistical analyses were performed using Statistica (version 5.5; StatSoft
Inc, Tulsa, Oklahoma). Adjustment for multiple comparisons (false discov-
ery rate, FDR) was performed for all the genes data.
3 | RESULTS
3.1 | Genetically determined differences between
nPE1−/− and nPE1+/+ male mice in alcohol intake and
preference during chronic alcohol drinking in DID and
IA models
On both day 1 and day 4 during the exposure to 4-day alcohol drink-
ing in the DID model, nPE1−/− drank less alcohol than nPE1+/+
(Table 1A). Two-way ANOVA showed significant effects of genotype
(F(1,20) = 48, P < .00001) and time (F(1,20) = 44, P < .00005) on alcohol
intake. Post-hoc analysis showed that: (a) in nPE1+/+, there was signifi-
cantly more alcohol intake on day 4 than that on day 1 (P < .01); (b) in
nPE1−/−, there was significantly more alcohol intake on day 4 than
that on day 1 (P < .01); and (c) nPE1−/− had significantly less alcohol
intake than nPE1+/+ on both day 1 and day 4 (P < .01 for both).
The nPE1+/+ exposed to the IA model for 3 weeks showed alcohol
intake averaging approximately 19 g/kg/day, with high preference
ratio more than 0.8. In the nPE1−/−, however, alcohol intake increased
over days, but did not reach high consumption (around 10 g/kg/day)
with less preference ratio. As shown in Table 1B on alcohol intake,
three-way ANOVA showed significant effects of genotype
(F(1,60) = 79, P < .000001), interaction between genotype × time
(F(2,60) = 13, P < .0005); and session (F(1,60) = 37, P < .000001). Post-
hoc analysis showed that: (a) in session 1, nPE1−/− had significantly
less alcohol intake at both 8 and 24 hours than nPE1+/+ (P < .05 and
P < .01, respectively); (b) in session 10, nPE1−/− had significantly less
alcohol intake at 8 and 24 hours than nPE1+/+ (P < .01 for both); (c) at
4 and 24 hours, nPE1+/+ had significantly more alcohol intakes in ses-
sion 10 than those in session 1 (P < .05 and P < .01, respectively); and
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(d) at 24 hours, nPE1−/− had significantly more alcohol intake in ses-
sion 10 than that in session 1 (P < .01). On alcohol preference, three-
way ANOVA showed significant effects of genotype (F(1,60) = 45,
P < .00001), session (F(1,60) = 85, P < .000001) and interaction
between genotype × session (F(2,60) = 5.7, P < .05). Post-hoc analysis
showed that: (a) in session 1, nPE1−/− had significantly less preference
at 4, 8 and 24 hours than nPE1+/+ (P < .05, P < .01 and P < .01,
respectively); (b) in session 10, nPE1−/− had significantly less alcohol
preference at 4 hours than nPE1+/+ (P < .05); (c) nPE1+/+ had signifi-
cantly more preference in session 10 at 4 hours than that in session
1 (P < .05); and (d) nPE1−/− had significantly more preference in ses-
sion 10 at 4, 8 and 24 hours than those in session 1 (P < .01 for all).
As shown in Table 2, there was a significant effect of genotype on
BEC levels (F(1,10) = 8.5, P < .01), which were associated with their
differences in alcohol intake (F(1,10) = 5.5, P < .05) between the
nPE1+/+ and nPE1−/− mice.
3.2 | Genetically determined differences between
nPE1−/− and nPE1+/+ male mice in opioid genes
transcript levels after chronic alcohol drinking
3.2.1 | Pomc and Oprm1 (MOP-r gene)
For Pomc (Figure 1A), two-way ANOVA showed significant effects of
alcohol (F(1,19) = 18, P < .001) and genotype (F(1,19) = 4.8, P < .05], with-
out alcohol × genotype interaction. Newman-Keuls post-hoc tests just
failed to show a significant difference between nPE1−/− and nPE1+/+ in
water control groups (P = .09). Increased Pomc levels were observed in
nPE1+/+ after alcohol (post-hoc tests, alcohol vs water in nPE1+/+,
P < .05) (FDR = 0.12). Similarly, Pomc levels were significantly higher in
nPE1−/− after alcohol than those after water (P < .05) (FDR = 0.08).
For Oprm1 (Figure 1B), two-way ANOVA showed a significant
effect of genotype (F(1,19) = 5.3, P < .05) with no significant effect of
alcohol (F(1,19) = 3.5, P = .08) or alcohol × genotype interaction.
Although post-hoc tests failed to show a significant difference
between nPE1−/− and nPE1+/+ in water groups (P = .10), a planned
comparison showed that basal Oprm1 levels were significantly higher
in nPE1−/− than nPE1+/+ (P < .05) (FDR = 0.08). Increased Oprm1
levels were observed in nPE1+/+ after alcohol (alcohol vs water in
nPE1+/+, P < .05) (FDR = 0.17).
TABLE 1 Genotype differences on alcohol intake in 4-day drinking-in-the-dark (DID) model (A) and on alcohol intake and alcohol preference
in chronic (3 weeks) intermittent access excessive drinking model (B) between male nPE1+/+ and nPE1−/− mice. (A) in DID model, alcohol was
presented 3 hours after the beginning of dark cycle, and alcohol intake was recorded after 4 hours of alcohol access for 4 days in the nPE1+/+ and
nPE1−/− mice
A. Alcohol intake (g/kg) on day 1 and day 4 in DID model
Day 1 Day 4
Genotype nPE1+/+ nPE1−/− nPE1+/+ nPE1−/−
Alcohol intake 4.1 ± 0.35 1.1 ± 0.38 ** 5.8 ± 0.35 ++ 3.9 ± 0.63 ** ++
B. Alcohol intake (g/kg) and preference ratio in session 1 and session 10 in chronic IA model
Session 1 Session 10
nPE1+/+ nPE1−/− nPE1+/+ nPE1−/−
Alcohol intake
g/kg
4 h 3.9 ± 0.43 1.9 ± 0.28 5.6 ± 0.59 + 2.7 ± 0.43
8 h 5.3 ± 0.51 2.3 ± 0.34 * 9.7 ± 0.59 4.5 ± 0.74 **
24 h 13 ± 2.3 4.9 ± 0.90 ** 19 ± 2.0 ++ 9.5 ± 1.2 ** ++
Alcohol preference ratio 4 h 0.59 ± 0.10 0.38 ± 0.07 * 0.86 ± 0.02 + 0.63 ± 0.05 * ++
8 h 0.67 ± 0.05 0.34 ± 0.13 ** 0.81 ± 0.04 0.60 ± 0.07 ++
24 h 0.54 ± 0.06 0.38 ± 0.06 ** 0.73 ± 0.04 0.61 ± 0.06 +
Genotype difference: **P < .01 vs nPE1+/+ at the same day; Day difference: ++P < .01 vs the same genotype on day 1 by 2-way ANOVA with Newman-
Keuls post-hoc tests (n = 6 for each group); (B) in IA model, mice exposed to the 2-bottle “alcohol (15%) vs water” choice regimen every other day for
3 weeks. Data are presented after 4, 8 and 24 hours of alcohol access in the session 1 and in the session 10 during 3 weeks of chronic IA excessive alcohol
drinking.
Genotype difference: *P < .05 or **P < .01 vs nPE1+/+ at the same time point in the same session; Session difference: +P < .05 or ++P < .01 vs the same
genotype at the same time point in the session 1 by 3-way ANOVA with Newman-Keuls post-hoc tests (n = 6 for each group). Data presented as
mean ± SEM.
TABLE 2 Genotype difference in blood ethanol concentration
(BEC) in male nPE1 mice. After mice were subjected to the 4-day DID
paradigm followed by a 3-week IA drinking paradigm, in session
11 after 4-hour alcohol drinking, blood from each mouse was
collected for BEC levels
Genotype nPE1+/+ (n = 6) nPE1−/− (n = 6)
Alcohol intake, g/kg 5.4 ± 0.49 2.9 ± 0.22*
BEC, mg/mL 0.49 ± 0.03 0.24 ± 0.03**
Genotype difference: *P < .05 or **P < .01 vs nPE1+/+ mice by Student's
t tests (n = 6 for each group). Data presented as mean ± SEM.
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3.2.2 | Pdyn (prodynorphin gene) and Oprk1 (KOP-
r gene)
For Pdyn (Figure 1C), two-way ANOVA showed significant effects of
genotype (F(1,20) = 5.3, P < .05) and alcohol × genotype interaction
(F(1,20) = 14.9, P < .001). Post-hoc tests showed basal Pdyn levels were
significantly lower in nPE1−/− than nPE1+/+ in water groups (P < .01)
(FDR = 0.03). Increased Pdyn levels were observed in nPE1−/− mice
after alcohol (alcohol vs water in nPE1−/−, P < .01) (FDR = 0.05).
For Oprk1 (Figure 1D), two-way ANOVA showed significant
effects of genotype (F(1,20) = 7.3, P < .05) with no significant effect of
alcohol (F(1,20) = 4.1, P = .05). Although post-hoc tests failed to show a
significant difference between nPE1−/− and nPE1+/+ in water groups
(P = .10), a planned comparison showed that basal Oprk1 level was sig-
nificantly higher in nPE1−/− than that in nPE1+/+ (P < .05)
(FDR = 0.08).
3.2.3 | Penk (proenkephalin gene) and Oprd1 (DOP-
r gene)
For Penk (Figure 1E), two-way ANOVA showed a significant effect of
genotype (F(1,19) = 5.5, P < .05). Compared with nPE1
+/+, decreased
Penk levels were observed in nPE1−/− mice after alcohol (alcohol
nPE1−/− vs alcohol nPE1+/+, P < .05) (FDR = 0.25).
For Oprd1 (Figure 1F), two-way ANOVA showed a significant
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F IGURE 1 Genetically determined differences between nPE1+/+ and nPE1−/− male mice and effects of acute (1-day) withdrawal from chronic
(4-week) excessive alcohol drinking on nuclear transcript levels (reads per kilobase per million per mapped reads) of opioid genes in the
hypothalamus: A, Pomc; B, Oprm1; C, Pdyn; D, Oprk1; E, Penk; F, Oprd1; G, Pnoc and H, Oprl1. *P < .05 or **P < .01 vs water control in the same
genotype; +P < .05 or ++P < .01 vs nPE1+/+ after the same treatment. n = 5-6 for each group. Data presented as mean RPKM (reads per kilobase
per million mapped reads) + SEM
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of alcohol (F(1,20) = 3.6, P = .07). Although post-hoc tests just failed
to show a significant difference between nPE1−/− and nPE1+/+ in
water groups (P = .05), a planned comparison showed that basal
Oprd1 level was significantly lower in nPE1−/− than that in nPE1+/+
(P < .05) (FDR = 0.08). Increased Oprd1 levels were observed in
nPE1−/− mice after alcohol (alcohol vs water in nPE1−/−, P < .05)
(FDR = 0.08).
3.2.4 | Pnoc (pronociceptin gene) and Oprl1
(nociceptin receptor gene)
For Pnoc (Figure 1G), two-way ANOVA showed a significant effect of
genotype (F(1,20) = 9.9, P < .01). Post-hoc tests showed basal Pnoc level
was significantly lower in nPE1−/− than that in nPE1+/+ in water
groups (P < .05) (FDR = 0.08).
For Oprl1 (Figure 1H), two-way ANOVA showed a significant
alcohol × genotype interaction (F(1,20) = 7.7, P < .05) with no
significant effect of genotype (F(1,20) = 2.9, P = .09). Post-hoc tests
showed basal Oprl1 level was significantly lower in nPE1−/− than that
in nPE1+/+ in water groups (P < .05) (FDR = 0.08). Increased Oprl1
levels were observed in nPE1−/− mice after alcohol (alcohol vs water
in nPE1−/−, P < .05) (FDR = 0.08).
3.3 | Genetically determined differences between
nPE1−/− and nPE1+/+ male mice in stress genes
transcript levels after chronic alcohol drinking
3.3.1 | Oxt (oxytocin gene) and Oxtr (oxytocin
receptor gene)
For Oxt (Figure 2A), two-way ANOVA showed significant effects of
genotype (F(1,20) = 4.8, P < .05) and alcohol × genotype interaction
(F(1,20) = 9.8, P < .01). Post-hoc tests showed basal Oxt level was signif-
icantly lower in nPE1−/− than that in nPE1+/+ in water groups (P < .01)





























































F IGURE 2 Genetically determined differences between nPE1+/+ and nPE1−/− male mice and effects of acute (1-day) withdrawal from chronic
(4-week) excessive alcohol drinking on nuclear transcript levels of stress genes in the hypothalamus: A, Oxt; B, Oxtr; C, Avp; D, Avpi1; E, Nr3c1
and F, Nr3c2. *P < .05 or **P < .01 vs water control in the same genotype; +P < .05 or ++P < .01 vs nPE1+/+ after the same treatment. n = 5-6 for
each group. Data presented as mean RPKM (reads per kilobase per million mapped reads) + SEM
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(FDR = 0.06). In nPE1+/+ mice, although post-hoc tests just failed to
show a significant difference (P = .08), a planned comparison showed
that Oxt levels after alcohol were significantly lower than the ones in
water control (P < .05) (FDR = 0.18). In nPE1−/−, increased Oxt levels
were observed after alcohol (alcohol vs water in nPE1−/−, P < .05)
(FDR = 0.10).
For Oxtr (Figure 2B), two-way ANOVA showed a significant alco-
hol x genotype interaction (F(1,19) = 5.3, P < .05). Post-hoc tests
showed basal Oxtr level was significantly lower in nPE1−/− than that
in nPE1+/+ in water groups (P < .05) (FDR = 0.09). In nPE1−/− mice,
increased Oxtr levels were observed after alcohol (alcohol vs water in
nPE1−/−, P < .05) (FDR = 0.08).
3.3.2 | Avp, Avpr1a (AVP type 1a receptor gene) and
Avpi1 (AVP-induced protein 1 gene)
For Avp (Figure 2C), two-way ANOVA showed a significant alcohol x
genotype interaction (F(1,20) = 14, P < .005). Although post-hoc tests
just failed to show a significant difference between nPE1−/− and
nPE1+/+ in water groups (P = .06), a planned comparison showed that
basal Avp level was significantly lower in nPE1−/− than that in nPE1+/+
(P < .05) (FDR = 0.08). In nPE1−/−, increased Avp levels were observed
after alcohol (alcohol vs water in nPE1−/−, P < .01) (FDR = 0.05). Com-
pared with nPE1+/+ mice, increased Avp levels were observed in
nPE1−/− mice after alcohol (alcohol nPE1−/− vs alcohol nPE1+/+ mice,
P < .05) (FDR = 0.25).
For Avpr1a (Table 3), two-way ANOVA showed a significant
alcohol × genotype interaction (F(1,20) = 4.7, P < .05). Although post-
hoc tests failed to show a significant difference between alcohol
and water in nPE1−/− (P = .09), a planned comparison showed that
there was an increased Avpr1a levels after alcohol (P < .05)
(FDR = 0.26).
For Avpi1 (Figure 2D), two-way ANOVA showed significant
effects of alcohol (F(1,20) = 17.5, P < .0005) and alcohol × genotype
interaction (F(1,20) = 4.7, P < .05). In nPE1
+/+, decreased Avpi1 levels
were observed after alcohol (post-hoc tests, alcohol vs water in
nPE1+/+, P < .005) (FDR = 0.03).
3.3.3 | Crh, Crhr1 (CRH type 1 receptor gene), Crhr2
(CRH type 2 receptor gene) and Crhbp (CRH binding
protein gene)
For these genes, there was no significant effect of genotype, alcohol
or their interaction (Table 3).
3.3.4 | Nr3c1 (glucocorticoid receptor gene), Nr3c2
(mineralocorticoid receptor gene) and Fkbp5 (FK506
binding protein 5 gene)
For Nr3c1 (Figure 2E), two-way ANOVA showed a significant effect
of alcohol (F(1,20) = 14.8, P < .001) with no significant effect of geno-
type (F(1,20) = 3.8, P = .06). Post-hoc tests showed basal Nr3c1 level
was significantly higher in nPE1−/− than that in nPE1+/+ in water
groups (P < .05) (FDR = 0.09). In nPE1+/+, although post-hoc tests just
failed to show a significant difference (P = .08), a planned comparison
showed that Nr3c1 levels after alcohol were significantly lower than
the ones in water control (P < .05) (FDR = 0.18). In nPE1−/− mice,
decreased Nr3c1 levels were also observed after alcohol (alcohol vs
water in nPE1−/−, P < .05) (FDR = 0.05).
For Nr3c2 (Figure 2F) or Fkbp5 (Table 3), there was no significant
effect of genotype, alcohol or their interaction.
3.4 | Regression analysis
Within the group of alcohol drinking mice, large individual differences
in alcohol intake were observed. Then, linear regression between the
last 24-hour alcohol intake and each nuclear mRNA transcript levels
were further analyzed in both the nPE1+/+ and nPE1−/− mice, and cor-
relation coefficient and p values were shown from Figure S2 to
Figure S9.
3.5 | Genetically determined differences between
nPE1−/− and nPE1+/+ male mice in plasma
corticosterone levels after chronic alcohol drinking
Two-way ANOVA showed a significant effect of genotype
(F(1,20) = 38, P < .0001) with no significant effect of alcohol
(F(1,20) = 3.9, P = .06). Post-hoc tests showed that basal plasma cortico-
sterone level was significantly higher in nPE1−/− in water group (96
± 16 ng/mL, n = 6) than that in nPE1+/+ in water groups (41
± 7 ng/mL, n = 6) (P < .005). Compared with the water control,
nPE1+/+ had a decrease in plasma corticosterone levels after alcohol
(14 ± 2 ng/mL, n = 6), but post-hoc tests just failed to show a signifi-
cant difference (P = .06). Compared with nPE1+/+ after alcohol,
increased plasma corticosterone levels were observed in nPE1−/−
after alcohol (84 ± 10 ng/mL, n = 6) (alcohol nPE1−/− vs alcohol
nPE1+/+, P < .005).
TABLE 3 Genetically determined differences between nPE1+/+
and nPE1−/− male mice and effects of acute (1-day) withdrawal from
chronic (4-week) excessive alcohol drinking on nuclear transcript
levels in the hypothalamus
nPE1+/+ (n = 6) nPE1−/− (n = 6)
Water Alcohol Water Alcohol
Avpr1a 80 ± 10 74 ± 3 65 ± 5 85 ± 7 *
Crh 70 ± 13 80 ± 8 56 ± 9 68 ± 9
Crhr1 103 ± 24 87 ± 5 71 ± 5 88 ± 6
Crhr2 61 ± 3 60 ± 4 48 ± 12 70 ± 7
Crhbp 178 ± 20 142 ± 6 154 ± 18 165 ± 17
Fkbp5 325 ± 65 292 ± 14 231 ± 16 282 ± 17
Genotype difference: *P < .05 vs water control in the same genotype
(n = 6 for each group). Data presented as mean RPKM (reads per kilobase
per million mapped reads) ± SEM.
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3.6 | Genetically determined differences between
nPE1−/− and nPE1+/+ male mice in the effect of mu
opioid receptor antagonist naltrexone on chronic
alcohol drinking
At 1 mg/kg naltrexone (Table 4A), there was no significant effect of
this low-dose naltrexone on alcohol, water and alcohol preference
ratio in either nPE1+/+ or nPE1−/− mice. Three-way ANOVA showed
significant effects of genotype (F(1,48) = 48, P < .0001) and interaction
between genotype × time (F(2,48) = 4.4, P < .05) on alcohol intake.
Post-hoc analysis showed that nPE1−/− had significantly less alcohol
intake at 8- and 24-hour time points than nPE1+/+ (P < .05). Also,
three-way ANOVA showed a significant effect of genotype
(F(1,48) = 34, P < .001) only on alcohol preference.
At 2 mg/kg, naltrexone reduced alcohol intake in nPE1+/+ only
(Table 4B). Three-way ANOVA showed significant effects of genotype
(F(1,48) = 43, P < .0001), time (F(2,48) = 42, P < .0001), interaction
between genotype × time (F(2,48) = 5.8, P < .01) and naltrexone at
2 mg/kg (F(1,48) = 15, P < .005) on alcohol intake. Post-hoc analysis
showed that (a) nPE1−/− had significantly less alcohol intake at 8- and
24-hour time points than nPE1+/+ (P < .05); and (b) naltrexone at
2 mg/kg significantly reduced alcohol intake at 4- and 24-hour time
point in nPE1+/+ only (P < .05). Three-way ANOVA showed significant
effects of genotype (F(1,48) = 25, P < .01) and naltrexone at 2 mg/kg
(F(1,48) = 6.9, P < .01) on alcohol preference.
4 | DISCUSSION
4.1 | Genetically determined differences in opioid
genes transcript levels, alcohol consumption and the
effect of naltrexone
Using nuclear RNA-Seq with the Pomc enhancer1 deletion (nPE1−/−)
mice with hypothalamic-specific partial loss of Pomc transcriptional
activity, the present study confirmed the genotype difference: the
nPE1−/− mice, in comparison with the nPE1+/+ mice, had lowered
nuclear Pomc transcript levels in the hypothalamus (Figure 1A), as
reported before at cytoplasmic Pomc mRNA levels.12 Our preliminary
data showed the Pomc mRNA levels in the nucleus accumbens were
unaltered in the nPE1 knock male mice (Result S1). Of interest, the
nPE1−/− mice displayed lower alcohol intake (approximately
9 g/kg/day) and preference (approximately 0.60 preference ratio), as
compared with nPE1+/+ mice with higher levels of alcohol intake
(approximately 19 g/kg/day) and preference (approximately 0.81
preference ratio) (Table 1 and Figure S2). Although chronic alcohol
drinking for 4 weeks resulted in increases in the Pomc transcripts in
TABLE 4 Genetically determined differences in the effect of mu opioid receptor antagonist naltrexone at 1 mg/kg (A) and 2 mg/kg (B) on
alcohol drinking in nPE1 male mice. The groups assigned as the vehicle- or naltrexone-treated mice in each genotypes had similar alcohol intake
24 hours before the test day (data not shown). On the test day, alcohol (15%) was presented 10 minutes after a single i.p. injection of naltrexone
in saline or vehicle, and then alcohol and water intake values were recorded after 4, 8 and 24 hours of alcohol access. In these experiments, mice
were assigned to one of four treatment groups: (a) nPE1+/+ with vehicle as control; (b) nPE1+/+ with naltrexone; (c) nPE1−/− with vehicle as
control; and (d) nPE1−/− with naltrexone. Data are presented at all the three recording time points
A. No effects of naltrexone at 1 mg/kg on either nPE1+/+ or nPE1−/− mice
Genotype nPE1+/+ (n = 5) nPE1−/− (n = 5)
Treatment Vehicle 1 mg/kg naltrexone Vehicle 1 mg/kg naltrexone
Alcohol intake
g/kg
4 h 5.4 ± 1.4 4.8 ± 1.5 2.6 ± 1.4 3.0 ± 0.41
8 h 9.8 ± 2.6 8.8 ± 2.2 4.2 ± 0.9 * 3.5 ± 0.57 *
24 h 17.6 ± 2.4 18.1 ± 2.9 8.9 ± 2.2 * 7.3 ± 2.1 *
Alcohol preference 4 h 0.80 ± 0.04 0.74 ± 0.11 0.59 ± 0.07 0.54 ± 0.15
8 h 0.71 ± 0.06 0.70 ± 0.05 0.57 ± 0.07 0.60 ± 0.11
24 h 0.65 ± 0.05 0.62 ± 0.04 0.50 ± 0.03 0.55 ± 0.13
B. Effects of naltrexone at 2 mg/kg on nPE1+/+, but not nPE1−/−, mice
Genotype nPE1+/+ (n = 5) nPE1−/− (n = 5)
Treatment Vehicle 2 mg/kg naltrexone Vehicle 2 mg/kg naltrexone
Alcohol intake
g/kg
4 h 6.1 ± 0.6 3.0 ± 0.5 + 2.8 ± 1.2 2.4 ± 0.91
8 h 10.1 ± 2.1 6.8 ± 2.1 3.7 ± 1.0 * 2.9 ± 0.60 *
24 h 18.0 ± 2.5 12.2 ± 1.3 + 9.1 ± 1.2 * 7.8 ± 1.8 *
Alcohol preference 4 h 0.82 ± 0.02 0.50 ± 0.06 0.61 ± 0.08 0.53 ± 0.10
8 h 0.70 ± 0.05 0.62 ± 0.04 0.56 ± 0.05 0.53 ± 0.15
24 h 0.66 ± 0.05 0.64 ± 0.03 0.49 ± 0.11 0.55 ± 0.12
Genotype difference: *P < .05 vs nPE1+/+ at the same time point after the same treatment; Naltrexone treatment difference: +P < .05 vs vehicle control in
the same genotype at the same time point by 3-way ANOVA with Newman–Keuls post-hoc tests. Data presented as mean ± SEM.
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both nPE1+/+ and nPE1−/− mice after acute 1-day withdrawal, Pomc
in the nPE1−/− mice were only restored to basal levels of nPE1+/+
mice. Furthermore, chronic alcohol drinking also increased Oprm1
transcripts in nPE1+/+ mice, but not in nPE1−/− mice with already
increased basal Opmr1 transcripts (Figure 1B). Activation of MOP-r
by beta-endorphin produces rewarding effects5,6 and alcohol
enhances beta-endorphin release and POMC biosynthesis in the
hypothalamus,2,3,8 which play an important role in the reinforcing
actions and motivational behaviors of alcohol drinking in rodents.
Therefore, both alcohol-induced Pomc and Opmr1 transcripts for the
ligand and receptor in nPE1+/+ mice may contribute to excessive
alcohol drinking (Table 5A). In contrast, the lowered alcohol prefer-
ence and intake in nPE1−/− mice may be attributed by the
genetically-determined Pomc transcripts with lowered basal level and
blunted response to alcohol.
We functionally examined the effect of pharmacological blockade
of MOP-r and found that naltrexone dose-dependently reduced
excessive alcohol intake and preference in nPE1+/+ mice, confirming
that naltrexone reduced alcohol consumption in our mouse model
(Table 4). Our data also suggest the possibility that chronic
alcohol/acute withdrawal may cause beta-endorphin release,9,10
which plays a functional role in enhancing nuclear Pomc transcript
levels in nPE1+/+ mice (Figure 1A). Our result is consistent with previ-
ous studies showing that beta-endorphin, MOP-r and POMC neurons
in the hypothalamus (the main brain region producing Pomc and beta-
endorphin) contribute to alcohol consumption.13,36-39 Consistently,
the pharmacological effect of naltrexone was blunted in nPE1−/−
mice, although the same naltrexone dose significantly reduced alcohol
drinking in nPE1+/+ mice (Table 4), further suggesting a lowered beta-
endorphin tone resultant from decreased Pomc transcript levels in the
nPE1−/− mice was involved in the lack of naltrexone response and
low alcohol intake. In line with the result on drinking behavior, the
observation of increased corticosterone levels in nPE1−/− mice indi-
cates less beta-endorphin activity with neuronal POMC partial defi-
ciency, as it is well known that the beta-endorphin/MOP-r plays an
inhibitory role in HPA hormonal activity in both humans and
rodents.11
In contrast to the increases in both Pomc and Oprm1 transcripts
(Figure 1A,B), neither Penk nor Oprd1 transcripts showed any changes
after alcohol in nPE1+/+ mice (Figure 1E,F). Although enkephalins can
also bind and activate MOP-r, the effect of naltrexone on alcohol
drinking in nPE1+/+ mice with no change of Penk transcripts strongly
indicates that Penk or enkephalins may not contribute much to the
MOP-r mediated increase in alcohol drinking. Our results agree well
with one early study showing that alcohol consumption was not
altered in Penk knockout mice.38 The lack of significant effect by nal-
trexone in nPE1−/− mice was not due to its lowered basal alcohol
intake or floor effect, as other compounds tested before (eg, KOP-r or
V1b antagonist) still significantly reduced alcohol intake in the nPE
knockout mice.13 Together, these findings suggest again that Pomc/
beta-endorphin, but not Penk/enkephalins, acting on MOP-r, have a
critical role in alcohol drinking.
Our study using nPE1 transgenic mice with region-specific POMC
partial deficiency12 further confirms that POMC neurons in the hypo-
thalamus contribute to alcohol consumption. Earlier studies using
beta-endorphin deficient mice showed inconsistent results by differ-
ent groups.38,40,41 The potential limitation of the global beta-
endorphin knockout mouse model is that it did not allow for clarifica-
tion of which specific regions of POMC cells (hypothalamus or other
possible brain regions or pituitary) are involved in alcohol behaviors.
As melanocortin (another neuropeptide derived from POMC) activates
melanocortin 4 receptor (MC4R) and decreases alcohol and food
consumption,3 the partial deficiency of Pomc/melanocortin in the
nPE1 knockout mice may be also involved in their alcohol consump-
tion and food intake, and further study is needed.
In rodents, KOP-r/dynorphin activation is associated with the neg-
ative reinforcement aspects of alcohol addictions, especially during
acute withdrawal.11,18,42-44 After chronic alcohol/acute withdrawal,
TABLE 5 Schematic diagram of genetically determined
differences between nPE1+/+ and nPE1−/− male mice and effects of
acute (1-day) withdrawal from chronic (4-week) excessive alcohol
drinking on nuclear transcript levels of opioid genes (A) and stress
genes (B) in the hypothalamus. “Increase,” “Decrease” or “No change




Treatment Water Alcohol Water Alcohol
Pomc Baseline Increase Decrease nc
Oprm1 Baseline Increase Increase Increase
Pdyn Baseline nc Decrease nc
Oprk1 Baseline nc Increase nc
Penk Baseline nc nc nc
Oprd1 Baseline nc Decrease nc
Pnoc Baseline nc Decrease nc
Oprl1 Baseline nc Decrease nc
B. Stress genes
Genotype nPE1+/+ nPE1−/−
Treatment Water Alcohol Water Alcohol
Oxt Baseline Decrease Decrease nc
Oxtr Baseline nc Decrease nc
Avp Baseline nc Decrease nc
Avpi1 Baseline Decrease nc nc
Avpr1a Baseline nc nc nc
Nr3c1 Baseline Decrease Increase nc
Nr3c2 Baseline nc nc nc
Fkbp5 Baseline nc nc nc
Crh Baseline nc nc nc
Crhbp Baseline nc nc nc
Crhr1 Baseline nc nc nc
Crhr2 Baseline nc nc nc
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there was a slight, but not significant, decrease in Pdyn and Oprk1 in
nPE1+/+ (Figure 1C,D). In nPE1−/− mice, there were lower basal Pdyn
transcript levels in the hypothalamus (Figure 1C), when compared
with nPE1+/+ mice. Probably due to the dynorphin deficiency, the
nPE1−/− mice showed a compensatory increase in basal Oprk1 tran-
scripts (Figure 1D). In contrast to nPE1+/+, nPE1−/− after acute with-
drawal from low alcohol intake restored the lowered Pdyn to basal
levels of nPE1+/+ mice.
As nociceptin and its receptor in the hypothalamus have strong
interactions with beta-endorphin/MOP-r and involved in alcohol
related behaviors,45 we also examined their transcripts expression and
found no change of either Pnoc or Oprl1 in nPE1+/+ mice after chronic
alcohol/acute withdrawal (Figure 1G,H). Like Pdyn, however, acute
withdrawal from low alcohol drinking in nPE1−/− mice revered the
decreased Pnoc and Oprl1 to the basal levels of nPE1+/+ mice
(Table 5A).
4.2 | Genetically determined differences in stress
genes transcript levels and corticosterone levels
After acute withdrawal, oxytocin system was profoundly altered as
Oxt transcript level was reduced in the hypothalamus of nPE1+/+ mice
(Figure 2A) (Table 5B). Our finding is consistent with many studies
showing that there are alcohol-withdrawal related decreases in Oxt or
Avp cytoplasmic mRNA and peptide levels in the hypothalamus
(including the paraventricular nucleus) of mice, rats and
humans.14,46-49 In several selectively bred alcohol drinking rat lines,
there are lower basal levels of Avp mRNA in the hypothalamus of
Indiana and Sardinian alcohol non-preferring rats, as compared with
their alcohol preferring counterparts.48,50 Consistent to this notion,
the present study showed a lower basal Avp transcript level in
nPE1−/− mice, which could contribute to their lowered alcohol con-
sumption and/or preference.
Both CRH/CRH1 receptor and AVP/V1b receptor systems are
potent modulator of HPA axis and central stress responses. The pre-
sent study found that the low Avp transcript levels in the hypothala-
mus were associated with low plasma corticosterone levels after
acute withdrawal in nPE1+/+ mice. Different from Avp, there was no
change of Crh, Crhr1, Crhr2 or Crhbp transcript levels in nPE1+/+ hypo-
thalamus (Table 3), indicating that the AVP/V1b receptor system is
specifically involved in the HPA modulation during acute alcohol with-
drawal. Also, our results on plasma corticosterone levels after acute
withdrawal confirm previous findings.51 Our new observation of low
Nr3c1 transcript levels in nPE1+/+ mice (Figure 2E) suggests a
decreased glucocorticoid receptor expression and feedback activity
mediated by the receptors. In contrast, nPE1−/− mice showed high
basal levels of Nr3c1 and plasma corticosterone, indicating that
upregulated HPA activity may lead to less alcohol intake in the
nPE1−/− mice.11
AVP-induced protein 1 was reported to function in MAP kinase
activation, epithelial sodium channel down-regulation and cell
cycling.52 Here we unexpectedly observed a profound decrease of
Avpi1 transcript levels in the nPE1+/+ hypothalamus after chronic
alcohol drinking (Figure 2D), suggesting for the first time the potential
interaction between the AVP-induced protein 1 and excessive alcohol
drinking or withdrawal. Of interest, in a recent human genetic study,
rs7913179 variant in the Avpi1 gene is found to associate with alcohol
dependency in a genome-wide gene-by-alcohol dependence interac-
tion analysis in European men.53 Although the AVP/V1b receptor sys-
tem plays important roles in alcohol drinking,11,15 it seems unknown,
however, whether and how the hypothalamic AVP-induced protein
1 is involved in alcohol drinking behaviors, and further study is
needed.
Individual vulnerability to excessive alcohol drinking is a key fea-
ture of alcohol addiction. One focus of the present study was to
explore whether individual differences in mouse vulnerability to
excessive drinking may be related to genetically-determined individual
differences in key neurochemical systems in the hypothalamus. For
this purpose, we determined if the changes in individual opioid or
stress gene expression were correlated with vulnerability to excessive
alcohol intake between and within each genotype by regression analy-
sis (Figure S2-Figure S9). There were positive correlations between
Pomc, Penk, Oprd1, Nr3c1, Nr3c2 and Fkbp5 and a propensity for alco-
hol intake, and a negative correlation between the Avp and alcohol
intake. Although caution should be used when interpreting the rela-
tionships between behavior and transcript levels, our study of nuclear
transcriptome profiling in both the nPE1+/+ and nPE1−/− mice with
relatively high and low alcohol drinking provide useful information
about a potential role of individual variations in relation with alcohol
intake.
4.3 | Summary
The comprehensive and accurate characterization of transcriptional
activity represents an important step in the understanding of chronic
alcohol exposure in which gene expression occurs in the hypothalamic
neurons. Many studies, including ours, have found that chronic alco-
hol drinking resulted in persistent changes in cytoplasmic mRNA levels
of opioid and stress genes in rodent hypothalamus.11,15,19 In the pre-
sent study, we hypothesized that alcohol-induced transcriptional reg-
ulation in the nucleus is the critical step for maintaining the persistent
changes in cytoplasmic mRNA levels and then subsequent peptide
activity that is critically involved in excessive alcohol drinking. There-
fore, we investigated the effects of chronic alcohol and acute with-
drawal on opioid and stress gene expressions at nuclear
transcriptional activity in the hypothalamus. In this particular region,
we observed a stimulatory effect on Pomc and Oprm1 opioid gene
transcripts after acute withdrawal from chronic excessive drinking in
the wildtype mice (Table 5A), with an inhibitory effect on stress gene
transcripts (Oxt, Avpi1 and Nr3c1) (Table 5B), which may contribute to
the persistent alterations of the rewarding effect and stress
responses. Of interest, the opioid and stress gene transcription activi-
ties were differentially altered in the POMC-deficient mice with
genetically-determined basal expression levels and low alcohol intake.
The consequence of a new set point of the opioid and stress gene
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transcription activities in response to alcohol may play an important
role in individual vulnerability to excessive alcohol drinking.
The altered transcriptional activity has been found to correlate
with nuclear transcript levels both in the in vitro26-28 and in vivo27,29
studies. Specifically, nuclear RNA quantity can reflect the levels at
which transcriptional activity occurs in the cells for protein-coding
genes induced by different stimuli.26-28 Furthermore, several studies
have showed that altered cytoplasmic mRNA levels parallel the
changes of nuclear transcript levels, as the accumulation of cytoplas-
mic mRNAs (eg, Pomc) are mostly due to the increases in gene tran-
scriptional activity in the nucleus.27,28 Therefore, nuclear RNA-Seq in
the present study provides a representative description of nascent
transcriptional activity of the opioid and stress genes in response to
acute alcohol withdrawal. Therefore, nuclear RNA-Seq may recapitu-
late the transcript levels associated with activated neuronal trans-
criptome after acute withdrawal, enabling the identification of
nascent and neuronal activity-associated mRNAs. Together, our
results of the genetic, pharmacological and neuroendocrine analyses
using nPE1 knockout mice, MOP-r antagonist naltrexone and stress
hormone corticosterone together provide functional validation about
the transcriptome profiling in the hypothalamus.
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